The estimated Net Worth of Enterprise Associates 13 Lp... is at least $655 Tysiąc dollars as of 15 January 2014. Enterprise Lp owns over 512,500 units of GlycoMimetics Inc stock worth over $654,940 and over the last 11 years Enterprise sold GLYC stock worth over $0.
Enterprise has made over 1 trades of the GlycoMimetics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Enterprise bought 512,500 units of GLYC stock worth $4,100,000 on 15 January 2014.
The largest trade Enterprise's ever made was buying 512,500 units of GlycoMimetics Inc stock on 15 January 2014 worth over $4,100,000. On average, Enterprise trades about 512,500 units every 0 days since 2014. As of 15 January 2014 Enterprise still owns at least 4,093,377 units of GlycoMimetics Inc stock.
You can see the complete history of Enterprise Lp stock trades at the bottom of the page.
Over the last 11 years, insiders at GlycoMimetics Inc have traded over $15,299,593 worth of GlycoMimetics Inc stock and bought 10,868,557 units worth $48,421,008 . The most active insiders traders include Scott D Sandell, Peter J Barris oraz M James Barrett. On average, GlycoMimetics Inc executives and independent directors trade stock every 51 days with the average trade being worth of $38,210. The most recent stock trade was executed by Public Equities, L.P.Invus ... on 7 August 2024, trading 322,361 units of GLYC stock currently worth $61,249.
at glycomimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments. glycomimetics is a clinical-stage biotechnology company. we use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. since the company’s inception in 2003, we have developed a robust, diversified product pipeline. we are a public company traded on the nasdaq under the symbol glyc.
GlycoMimetics Inc executives and other stock owners filed with the SEC include: